Related Experiment Video
Updated: Aug 17, 2026
Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
Published on: January 19, 2024
Utilizing fractional resurfacing in the treatment of therapy-resistant melasma
Zeina S Tannous1, Susanne Astner
1Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. ztannous@partners.org
Background:
Multiple treatment modalities have been employed for the management of melasma with minimal to no success.
Objective:
We propose fractional resurfacing as a new treatment modality for melasma.
Methods:
A 31-year-old Caucasian female with facial epidermal and dermal melasma, resistant to multiple courses of topical therapies, was treated with two sessions of full-face fractional resurfacing (Fraxel(TM) Laser; Reliant technologies, San Diego, CA), separated by a three-week interval. Clinical improvement was assessed by Wood's Lamp examination as well as parallel and cross-polarized comparative photography at baseline and 6 months later.
Results:
Marked reduction in epidermal and dermal facial pigmentation was observed at the six-month follow-up visit.
Conclusion:
Fractional resurfacing may prove to be an effective and safe treatment modality for lightening of the epidermal and dermal pigmentation of melasma. Further studies with long-term follow-up periods and multiple patients with diverse skin phototypes and different variants of melasma are warranted.
